Yot Teerawattananon
Senior Researcher
Biography
Dr. Yot Teerawattananon is a founding leader of the Health Intervention and Technology Assessment Program (HITAP), which is a semi-autonomous research institute of Thailand’s Ministry of Public Health. The works of HITAP have been used to inform policy decisions regarding the adoption of medicines, medical devices, health promotion and disease prevention programmes under the Universal Health Coverage Scheme and the national pharmaceutical reimbursement list, the National List of Essential Medicines.
Yot has gone on to provide technical advice to many national and international agencies such as: the Gates Foundation, WHO, World Bank, Asian Development Bank and the Centre for Global Development (CGD), giving him a broad knowledge of key issues in global health. He is also one of the founders of HTAsiaLink, a regional networks comprising of governmental health technology assessment agencies in South Korea, Japan, China, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Bhutan and Thailand.
Learn more about him!
CEA studies may be prospective studies or modelled studies
CEA studies may be prospective studies or modelled studies. Would economic evaluations be called “modelled studies” (clinical outcome is taken from systematic review and meta-analysis) rather than collecting primary data to measure clinical outcomes? If data for clinical outcome is collected, sh...
Can discount rates use the country’s inflation rates, instead of using rates such as 3-6%, as indicated in some guidelines?
Can discount rates use the country’s inflation rates, instead of using rates such as 3-6%, as indicated in some guidelines?
If a hospital would like to undertake a study on economic evaluation, what threshold should the hospital use? Since threshold is applied on a national level, can the hospital simply use ACER instead of ICER? Many
If a hospital would like to undertake a study on economic evaluation, what threshold should the hospital use? Since threshold is applied on a national level, can the hospital simply use ACER instead of ICER? Many
Why should countries consider using MCDA, in addition to economic evaluations?
Why should countries consider using MCDA, in addition to economic evaluations?
How to prevent drug companies to mess with my economic evaluation study??
How to prevent drug companies to mess with my economic evaluation study?
Expected Value of Perfect Information
How useful really is Expected Value of Perfect Information as an additional analysis to support decision-making for the healthcare system? Are there settings/countries now who are conducting this as part of their standard analysis to complement the results of cost effectiveness analysis?
WHO threshold report for outcomes other than DALY
Hello there. I am conducting a thesis on CEA. my outcome report is in cost per HIV positive client identified. The WHO threshold recommend GDP per capita compared with cost per DALY averted. I saw one study report their finding in cost per positive client identified and compare it with the country'...
tools or instrument or scale
Hi we are going to make a change in some health care programs, now i'm looking for some valid tools, scales,...which can help to assess cost-effectiveness of new program. I want to assess cost-effectiveness of new program based on it's needed equipment, facilities, employees, and space. Is there ...
how to conduct an economic evaluation of already existing program?
There is a program in my country which have started a decade ago. The government want to conduct economic evaluation of that program in a health facility. The program has both curative and preventive interventions for primary health care (vaccination, de-worming, family health, health education and ...
Choice of journal for publication
Which journal should I go for a publication of research on Economic evaluation of vaccine?
Is life year gained (LYG) estimate suitable for use with the WHO threshold?
We did a cost-effectiveness study of a program using LiST spectrum. We have reported our findings in cost per life year gained (LYG). Is it possible to compare the cost per LYG with the WHO GDP/capita threshold? The GDP/capita of the WHO is in cost per DALY. Or, is there a way to convert LYG to DALY...
How to transfer distribution of probability parameter from 5 years into 1 year
Dear Dr and Prof, I'm trying to find probability parameters for my model of chronic hepatitis B. However, most study I found come from observational studies, with different duration of follow-up . In my model, I need the probability and the parameters for beta distribution (alpha, beta). And I don'...